Treatment for Obstructive Sleep Apnea
Primary Treatment: Positive Airway Pressure Therapy
Continuous positive airway pressure (CPAP) or auto-adjusting PAP (APAP) is the first-line treatment for all adults with OSA, regardless of severity, and should be initiated immediately upon diagnosis. 1, 2, 3
CPAP/APAP Initiation and Selection
- Both CPAP and APAP are equally effective for ongoing treatment and can be used interchangeably. 1, 2
- PAP therapy can be initiated using either APAP at home or in-laboratory PAP titration in adults with OSA and no significant comorbidities—both methods show no clinically significant differences in adherence, sleepiness reduction, or quality of life improvement. 1, 2
- Use CPAP or APAP over bilevel PAP (BPAP) for routine treatment of OSA. 1
Contraindications to Home APAP Initiation
APAP at home is not appropriate for patients with: 2
- Congestive heart failure
- Chronic opiate use
- Neuromuscular disease
- History of uvulopalatopharyngoplasty
- Oxygen requirements during sleep
- Central sleep apnea syndromes
These patients require in-laboratory titration. 2
Interface and Device Settings
- Use nasal or intranasal masks preferentially over oronasal or oral interfaces to minimize side effects and maintain efficacy. 4, 3
- Add heated humidification to all PAP devices to reduce dry mouth/throat, nasal congestion, and nosebleeds. 4, 3
Adherence Optimization (Critical for Success)
- Provide educational interventions at PAP therapy initiation—this is a strong recommendation that significantly improves adherence. 1, 4, 3
- Implement behavioral and troubleshooting interventions during the initial period of PAP therapy. 1
- Use telemonitoring-guided interventions during the initial treatment period to identify and address problems early. 1, 2
- Establish adequate follow-up with objective monitoring of efficacy and usage data to ensure adequate treatment and adherence. 1, 4
- Patients should use PAP for the entirety of their sleep period, though even partial use (less than 4 hours per night) provides benefits and should be encouraged rather than discontinued. 4
Clinical Efficacy of PAP Therapy
PAP therapy demonstrates: 2, 4, 3
- Strong evidence for reducing excessive sleepiness
- Improvement in sleep-related quality of life
- Reduction in comorbid hypertension
- Normalization of traffic accident risk
- Decreased cardiovascular morbidities
- Normalization of mortality in severe OSA
Adjunctive Treatment: Weight Loss
All overweight and obese patients with OSA must be encouraged to lose weight as obesity is the primary modifiable risk factor for OSA. 2, 3
- Target BMI of 25 kg/m² or less. 1
- Weight reduction in obese patients improves breathing patterns, sleep quality, and daytime sleepiness. 1
- Weight loss provides improvement in OSA severity and should be used as adjunctive therapy alongside PAP. 4
Alternative Treatments for PAP-Intolerant Patients
Mandibular Advancement Devices (MADs)
MADs are the preferred alternative for patients who cannot tolerate CPAP, particularly in mild to moderate OSA. 1, 2, 3
- MADs are appropriate for patients who prefer them over CPAP, experience CPAP adverse effects, or cannot tolerate CPAP therapy. 1, 2, 3
- MADs are less effective than CPAP for severe OSA but demonstrate comparable effects on daytime sleepiness and quality of life measures with better adherence rates. 1
- Predictors of MAD success include: younger age, lower BMI, smaller neck circumference, female gender, lower AHI, and position-dependent OSA. 1
- Requires adequate dentition, periodontal health, and proper dental evaluation before initiation. 1
Hypoglossal Nerve Stimulation
Consider hypoglossal nerve stimulation for patients with AHI 15-65/h and BMI <32 kg/m² who cannot adhere to PAP therapy. 4, 3
- This represents an emerging therapy for select CPAP-intolerant patients. 2
Maxillomandibular Advancement Surgery
Maxillomandibular advancement surgery should be considered for severe OSA patients who cannot tolerate or are not appropriate candidates for other recommended therapies. 4, 3
- This surgery appears as efficient as CPAP in patients who refuse conservative treatment. 3
Treatments NOT Recommended
Ineffective or Inferior Options
- Positional therapy is clearly inferior to CPAP with poor long-term compliance and should not be used as primary therapy. 4, 3
- Oxygen therapy is not recommended as stand-alone treatment for OSA. 4, 3
- Drugs, nasal dilators, and apnea-triggered muscle stimulation cannot be recommended as effective OSA treatments. 4, 3
- Pharmacologic agents lack sufficient evidence and should not be prescribed for OSA treatment. 3
Common Pitfalls and How to Avoid Them
Adherence Failure
- The major cause of PAP treatment failure is lack of acceptance and inadequate adherence, not device inefficacy. 5
- Address adherence issues proactively with education, mask adjustments, and humidification before abandoning CPAP. 3
- CPAP adherence can be as low as 50% in certain populations, making early intervention critical. 6
Inappropriate Alternative Therapy Selection
- Do not offer MADs as first-line therapy for severe OSA—they are less effective than CPAP for normalizing respiratory parameters. 1
- Do not use home APAP initiation in patients with significant comorbidities listed above. 2